2022 annual financial data
Theravance Biopharma 2022 Operating margin
Theravance Biopharma 2022 operating margin with verified reported values.
Direct answer
Operating margin was -179.09%.
Operating income was -91,957,000 USD and net income was 872,132,000 USD.
Operating cash flow was -186,991,000 USD.
Get free Theravance Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 51,346,000 USD
- Operating income
- -91,957,000 USD
- Net income
- 872,132,000 USD
- Operating cash flow
- -186,991,000 USD